MEDICLINIC INTERNATIONAL PLC

Director's Dealing • Nov 15, 2016

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2579P

Mediclinic International PLC

15 November 2016

Mediclinic International PLC (the "Company")

(Incorporated in England and Wales)

Company Number: 08338604

LSE Share Code: MDC

JSE Share Code: MEI

NSX Share Code: MEP

ISIN: GB00B8HX8Z88

15 November 2016

NOTIFICATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1.

Details of PDMR / person closely associated with them ("PCA")

a)

Name

Petrus Jurgens Myburgh

2.

Reason for the notification

a)

Position / status

Chief Financial Officer of the Company

b)

Initial notification / amendment

Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mediclinic International plc

b)

LEI

N/A

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Identification Code

Ordinary Shares

GB00B8HX8Z88

b)

Nature of the transaction

Acquisition

c)

Price(s) and volume(s)

Price(s)	Volume(s)
ZAR136.46 per share	14,000

d)

Aggregated information

Aggregated volume

Price

N/A

e)

Date of the transaction

14 November 2016

f)

Place of the transaction

Johannesburg Stock Exchange 

Registered address: 1st Floor, 40 Dukes Place, London, EC3A 7NH, United Kingdom

Website: www.mediclinic.com

JSE sponsor: Rand Merchant Bank (A division of FirstRand Bank Limited)

NSX sponsor: Simonis Storm Securities (Pty) Ltd

For further information please contact:

Mediclinic International plc

James Arnold, Head of Investor Relations

ir@mediclinic.com

Capita Company Secretarial Services Limited

Victoria Dalby

+44 (0)207 954 9600

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBLBDBCGBBGLU